title: Emerging therapies for NASH - the future is now.
authors.affiliation: a Division of Hepatology, Department of Internal Medicine II , University Hospital Würzburg , Würzburg , Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Geier
authors.affiliation: a Division of Hepatology, Department of Internal Medicine II , University Hospital Würzburg , Würzburg , Germany.
authors.forename: Monika
authors.initials: M
authors.lastname: Rau
mesh_terms: D015195:Drug Design; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology
keywords: NAFLD; NASH; drug development; elafibranor; obeticholic acid; therapy